CORT108297

DRUG2 trials

Sponsors

VA Office of Research and Development, Johns Hopkins University

Conditions

Alzheimer DiseaseMemory ImpairmentMild Cognitive ImpairmentPTSD

Phase 2

Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)

RecruitingNCT04452500

VA Office of Research and DevelopmentPTSD

Start: 2022-10-15End: 2026-12-31Target: 40Updated: 2026-01-29

Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)

RecruitingNCT04601038

Johns Hopkins UniversityAlzheimer Disease, Memory Impairment, Mild Cognitive Impairment

Start: 2021-06-28End: 2028-01-01Target: 52Updated: 2026-07-13